MEL H. EPSTEIN
Physician at Poppasquash Rd, Bristol, RI
License number
Rhode Island MD06666
Issued Date
Jul 17, 1985
Expiration Date
Jun 30, 2018
Category
Physician
Type
Allopathic Physician (MD)
Address
Address
411 Poppasquash Rd, Bristol, RI 02809
Phone
(401) 254-5083 (Work)
Personal information
See more information about MEL H. EPSTEIN at radaris.comName
Address
Phone
55 Claverick St, Providence, RI 02903
411 Poppasquash Rd, Bristol, RI 02809
66 Claverick St, Providence, RI 02903
Professional information
See more information about MEL H. EPSTEIN at trustoria.com
Methods For Treating Cognitive Impairment In Humans With Multiple Sclerosis
Methods For Treating Cognitive Impairment In Humans With Multiple Sclerosis
US Patent:
7619005, Nov 17, 2009
Filed:
May 19, 2005
Appl. No.:
11/133144
Inventors:
Mel H. Epstein - Bristol RI, US
Kjesten A. Wiig - Providence RI, US
Randall L. Carpenter - Waban MA, US
Kjesten A. Wiig - Providence RI, US
Randall L. Carpenter - Waban MA, US
Assignee:
Cognition Pharmaceuticals LLC - New York NY
International Classification:
A61K 31/135, A61K 31/445
US Classification:
514654, 514317
Abstract:
Cognitive impairments in humans with multiple sclerosis are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
Methods For Treating Mild Cognitive Impairment And Alzheimer's Disease
Methods For Treating Mild Cognitive Impairment And Alzheimer's Disease
US Patent:
2005005, Mar 17, 2005
Filed:
Mar 2, 2004
Appl. No.:
10/791223
Inventors:
Mel Epstein - Bristol RI, US
Kjesten Wiig - Providence RI, US
Jeroen Verheijen - Cranston RI, US
Kjesten Wiig - Providence RI, US
Jeroen Verheijen - Cranston RI, US
Assignee:
Sention, Inc. - Providence RI
International Classification:
A61K031/137
US Classification:
514649000
Abstract:
Mild cognitive impairment and Alzheimer's disease are treated with an amphetamine compound. In one embodiment, the method includes administering an 1-amphetamine compound. In another embodiment, the method includes administering an 1-methamphetamine compound.
Methods For Treating Cognitive Impairment In Humans
Methods For Treating Cognitive Impairment In Humans
US Patent:
2010002, Jan 28, 2010
Filed:
Aug 6, 2008
Appl. No.:
12/221776
Inventors:
Mel H. Epstein - Bristol RI, US
Kjesten A. Wiig - Providence RI, US
Kjesten A. Wiig - Providence RI, US
Assignee:
Cognition Pharmaceuticals LLC - New York NY
International Classification:
A61K 31/137, A61P 25/00
US Classification:
514654
Abstract:
Cognitive impairments in humans with multiple sclerosis are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
Methods And Compositions For Regulating Memory Consolidation
Methods And Compositions For Regulating Memory Consolidation
US Patent:
2002011, Aug 22, 2002
Filed:
Oct 31, 2001
Appl. No.:
10/003740
Inventors:
Mel Epstein - Bristol RI, US
Kjesten Wiig - Providence RI, US
Kjesten Wiig - Providence RI, US
International Classification:
A61K031/137
US Classification:
514/649000
Abstract:
The present invention makes available methods and reagents for enhancing and/or restoring long-term memory function and performance, e.g., to improve long-term memory (LTM) and recall ability in animal subjects.
Methods For Treating Mild Cognitive Impairment And Alzheimer's Disease
Methods For Treating Mild Cognitive Impairment And Alzheimer's Disease
US Patent:
2010001, Jan 14, 2010
Filed:
Oct 31, 2008
Appl. No.:
12/291017
Inventors:
Mel H. Epstein - Bristol RI, US
Kjesten A. Wiig - Providence RI, US
Jeroen Verheijen - Cranston RI, US
Kjesten A. Wiig - Providence RI, US
Jeroen Verheijen - Cranston RI, US
Assignee:
Cognition Pharmaceuticals, LLC - New York NY
International Classification:
A61K 31/137, A61P 25/28
US Classification:
514654
Abstract:
Mild cognitive impairment and Alzheimer's disease are treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
Methods Of Treating Memory And Cognitive Impairments In Humans Following Stroke And Traumatic Brain Injury
Methods Of Treating Memory And Cognitive Impairments In Humans Following Stroke And Traumatic Brain Injury
US Patent:
2007019, Aug 23, 2007
Filed:
Dec 8, 2006
Appl. No.:
11/636703
Inventors:
Mel Epstein - Bristol RI, US
Kjesten Wiig - Providence RI, US
Kjesten Wiig - Providence RI, US
International Classification:
A61K 31/137
US Classification:
514649000
Abstract:
Cognitive impairments are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
Methods And Compositions For Regulating Memory Consolidation
Methods And Compositions For Regulating Memory Consolidation
US Patent:
2006016, Jul 27, 2006
Filed:
Dec 15, 2005
Appl. No.:
11/305495
Inventors:
Mel Epstein - Bristol RI, US
Kjesten Wiig - Providence RI, US
Kjesten Wiig - Providence RI, US
International Classification:
A61K 31/137
US Classification:
514649000
Abstract:
The present invention makes available methods and reagents for enhancing and/or restoring long-term memory function and performance.
Methods For Treating Alzheimer's Disease
Methods For Treating Alzheimer's Disease
US Patent:
2012014, Jun 7, 2012
Filed:
Jan 10, 2012
Appl. No.:
13/347415
Inventors:
Mel H. Epstein - Bristol RI, US
Kjesten A. Wiig - Providence RI, US
Mark F. Bear - Boston MA, US
Kjesten A. Wiig - Providence RI, US
Mark F. Bear - Boston MA, US
Assignee:
Cognition Pharmaceuticals LLC - New York NY
International Classification:
A61K 31/135, A61P 25/28, A61P 25/00
US Classification:
514654
Abstract:
Alzheimer's disease is treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
Use Of Threo-Methylphenidate Compounds To Enhance Memory
Use Of Threo-Methylphenidate Compounds To Enhance Memory
US Patent:
2002010, Aug 1, 2002
Filed:
Aug 28, 2001
Appl. No.:
09/941238
Inventors:
Mel Epstein - Bristol RI, US
Kjesten Wiig - Providence RI, US
Kjesten Wiig - Providence RI, US
International Classification:
A61K031/675, A61K031/445, A61K031/397, A61K031/40, A61K031/38
US Classification:
514/079000, 514/183000, 514/210010, 514/315000, 514/326000, 514/408000, 514/430000, 514/449000
Abstract:
The present invention makes available methods and reagents for facilitating memory, e.g., to increase memory function such as long-term memory and recall ability.
Use Of Methylphenidate Compounds To Enhance Memory
Use Of Methylphenidate Compounds To Enhance Memory
US Patent:
2002013, Sep 19, 2002
Filed:
Feb 28, 2002
Appl. No.:
10/087232
Inventors:
Mel Epstein - Bristol RI, US
Kjesten Wiig - Providence RI, US
Kjesten Wiig - Providence RI, US
International Classification:
A61K031/675, A61K031/445, G06F017/60
US Classification:
514/079000, 514/317000, 705/002000
Abstract:
The present invention makes available methods and reagents for facilitating memory, e.g., to increase memory function such as long-term memory and recall ability. Memory is increased by increasing attention and long term consolidation.